Capecitabine 150 mg film-coated tablets

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

şimdi satın al

Ürün özellikleri Ürün özellikleri (SPC)
06-04-2019

Aktif bileşen:

Capecitabine

Mevcut itibaren:

Fresenius Kabi Deutschland GmbH

ATC kodu:

L01BC; L01BC06

INN (International Adı):

Capecitabine

Doz:

150 milligram(s)

Farmasötik formu:

Film-coated tablet

Terapötik alanı:

Pyrimidine analogues; capecitabine

Yetkilendirme durumu:

Not marketed

Yetkilendirme tarihi:

2012-11-09

Bilgilendirme broşürü

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
CAPECITABINE 150 MG FILM-COATED TABLETS
CAPECITABINE 500 MG FILM-COATED TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet.
IN THIS LEAFLET:
1.
What Capecitabine is and what it is used for
2.
What you need to know before you take Capecitabine
3.
How to take Capecitabine
4.
Possible side effects
to the chest jaw and back brought on by physical effort and due to
problems with
the blood flow to the heart)
-
if you have brain diseases (for example. cancer that has spread to the
brain, or
nerve damage (neuropathy)
-
if you have calcium imbalances (seen in blood tests)
-
if you have diabetes
-
if you cannot keep food or water in your body because of severe nausea
and
vomiting
-
if you have diarrhoea
-
if you are or become dehydrated
-
if you have imbalances of ions in your blood (electrolyte imbalances,
seen in tests)
-
if you have a history of eye problems as you may need extra monitoring
of your
eyes
-
if you have a severe skin reaction.
_DPD DEFICIENCY_: DPD deficiency is a rare condition present at birth
that is not usually
associated with health problems unless you receive certain medicines.
If you have
an unrecognised DPD deficiency and take capecitabine, you may
experience severe
3. HOW TO TAKE CAPECITABINE
Always take this medicine exactly as your doctor or pharmacist has
told you. Check
with your doctor or pharmacist if you are not sure.
Capecitabine should only be prescribed by a doctor experienced in the
use of
anticancer medicines.
Capecitabine tablets should be
SWALLOWED WHOLE WITH WATER A
                                
                                Belgenin tamamını okuyun
                                
                            

Ürün özellikleri

                                HealthProductsRegulatoryAuthority
05April2019
CRN008RV0
Page1of22
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Capecitabine150mgfilm-coatedtablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Eachfilm-coatedtabletcontains150 mgcapecitabine.
Excipient(s)withknowneffect:
12mglactosemonohydrate(150mgtablet).
Forthefulllistofexcipients,seesection6.1.
3 PHARMACEUTICAL FORM
Film-coatedtablet.
Pinkcoloured,capsuleshaped,biconvex,filmcoatedtablets,debossedwith“150”ononesideandplainonotherside.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
CapecitabineisindicatedfortheadjuvanttreatmentofpatientsfollowingsurgeryofstageIII(Dukes'stageC)coloncancer(see
section5.1).
Capecitabineisindicatedforthetreatmentofmetastaticcolorectalcancer(seesection
5.1).
Capecitabineisindicatedforfirst-linetreatmentofadvancedgastriccancerincombinationwithaplatinum-basedregimen(see
section5.1).
Capecitabineincombinationwithdocetaxel(seesection5.1)isindicatedforthetreatmentofpatientswithlocallyadvancedor
metastaticbreastcancerafterfailureofcytotoxicchemotherapy.Previoustherapyshouldhaveincludedananthracycline.
Capecitabineisalsoindicatedasmonotherapyforthetreatmentofpatientswithlocallyadvancedormetastaticbreastcancer
afterfailureoftaxanesandananthracycline-containingchemotherapyregimenorforwhomfurtheranthracyclinetherapyis
notindicated.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Capecitabineshouldonlybeprescribedbyaqualifiedphysicianexperiencedintheutilisationofanti-
                                
                                Belgenin tamamını okuyun
                                
                            

Bu ürünle ilgili arama uyarıları